A detailed history of Cura Wealth Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cura Wealth Advisors, LLC holds 571 shares of LLY stock, worth $583,390. This represents 0.17% of its overall portfolio holdings.

Number of Shares
571
Previous 422 35.31%
Holding current value
$583,390
Previous $329 Million 32.41%
% of portfolio
0.17%
Previous 0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$625.65 - $812.69 $93,221 - $121,090
149 Added 35.31%
571 $436 Million
Q2 2025

Aug 14, 2025

BUY
$713.71 - $898.95 $33,544 - $42,250
47 Added 12.53%
422 $329 Million
Q1 2025

May 15, 2025

BUY
$725.72 - $929.72 $272,145 - $348,645
375 New
375 $310 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cura Wealth Advisors, LLC Portfolio

Follow Cura Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cura Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cura Wealth Advisors, LLC with notifications on news.